Remedica Ltd named as one of Europe’s best in first ever ‘Ones to Watch’ list

We are delighted to share with you that Remedica has been named as ‘One to Watch’ in Europe in a list of business excellence published by the European Business Awards sponsored by RSM.

Remedica was chosen as it demonstrates exceptional achievement in one of the 12 European Business Awards’ categories and reflects the programme’s core values of innovation, success and ethics.  The ‘Ones to Watch’ for 34 countries across Europe can be found at www.businessawardseurope.com.

Charalambos Pattihis, CEO of Remedica said: “We’re very proud to have been selected as ‘One to Watch’ in Europe in The European Business Awards, which are widely recognised as the showcase for Europe’s most dynamic companies”. Adrian Tripp, CEO of the European Business Awards, Europe’s largest cross-sector business competition, said: “We wanted to recognise more widely the many incredible business success stories from across Europe.” He continued: “The talent, dedication and innovation at the heart of these companies create jobs and opportunity, and is what drives their country’s prosperity. The ‘Ones to Watch’ lists will set a benchmark of success for the European business community.”
For more information about the competition please go to www.businessawardseurope.com

About Remedica:
Remedica, a member of Ascendis Health Group, is a pharmaceutical company located in Cyprus which exports in more than 100 countries. Originally founded in 1960 by Mr Chris Pattichis as a CO2 manufacturer, today is specialising in the development, production and sale of high-quality, safe and efficacious pharmaceutical products for human use. It also markets a number of other health and care products. Its pharmaceutical range consists of a product portfolio of more than 300 generic, branded generic and over-the-counter (OTC) products in more than 100 countries. It offers products from various therapeutic categories including antineoplastic agents, antivirals, cardiovascular, central nervous system agents, gastrointestinal agents, respiratory tract agents, dermatological agents and anti-infective products. Currently, Remedica has 5 state-of-the-art factories all of which have been routinely inspected and approved by the health authorities of several European Union Member States including those of Cyprus, Germany, UK and Denmark as well as those of Australia, Brazil, Japan and many more. Its health and care portfolio contains products such as anti-cancer medicines, an area in which the company specialises, therapies for HIV/AIDS, and drugs to treat conditions of the central nervous and the cardiovascular systems.

About the European Business Awards:
The European Business Awards’ primary purpose is to support the development of a stronger and more successful business community throughout Europe.

The European Business Awards programme serves the European business community in three ways:
• It celebrates and endorses individuals’ and organisations’ success
• It provides and promotes examples of excellence for the business community to aspire to
• It engages with the European business community to create debate on key issues

The European Business Awards is now in its 11th year. Last year it engaged with over 33,000 businesses from 34 countries. Sponsors and partners include RSM, ELITE and PR Newswire